Please provide your email address to receive an email when new articles are posted on . The addition of amivantamab-vmjw to chemotherapy extended PFS among a subset of patients with non-small cell ...
Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of ...
Please provide your email address to receive an email when new articles are posted on . Combination therapies appeared associated with better outcomes than monotherapies for treatment of hormone ...
Rivoceranib plus Airuika demonstrates improvement for survival in patients with unresectable hepatocellular carcinoma, a subset of liver cancer. The treatment combination of rivoceranib (apatinib) and ...
Hosted on MSN
New approach for testing multiple treatment combinations at once could aid in development of cancer drugs
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their approach allows scientists to efficiently estimate how combinations of ...
Efficacy and safety of bronchial arterial chemoembolization (BACE) in combination with tislelizumab for non-small cell lung cancer (NSCLC): A phase II study.
The combination of Talzenna and Xtandi was approved for the treatment of adults with HRR gene-mutated metastatic castration-resistant prostate cancer. The Food and Drug Administration (FDA) approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results